Hookipa Pharma (HOOK) Short Interest Ratio & Short Volume $3.40 -0.02 (-0.58%) (As of 10:23 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Hookipa Pharma Short Interest DataHookipa Pharma (HOOK) has a short interest of 36,200 shares, representing 0.47% of the float (the number of shares available for trading by the public). This marks a 39.23% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 56,760 shares to cover all short positions.Current Short Interest36,200 sharesPrevious Short Interest26,000 sharesChange Vs. Previous Month+39.23%Dollar Volume Sold Short$137,198.00Short Interest Ratio1.1 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares12,055,000 sharesFloat Size7,760,000 sharesShort Percent of Float0.47%Today's Trading Volume1,186 sharesAverage Trading Volume56,760 sharesToday's Volume Vs. Average2% Short Selling Hookipa Pharma? Sign up to receive the latest short interest report for Hookipa Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHOOK Short Interest Over TimeHOOK Days to Cover Over TimeHOOK Percentage of Float Shorted Over Time Ad InvestorPlaceIs AI Hype Hiding the Big Picture?Jeff Bezos has loaded up on a tiny company being called "the Next Nvidia." If you've never heard of what I call "QaaS" technology, you need to see this now.Click here and get the details now. Hookipa Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202436,200 shares $137,198.00 +39.2%0.5%1.1 $3.79 10/15/202426,000 shares $94,900.00 -26.1%0.3%0.9 $3.65 9/30/202435,200 shares $151,360.00 -31.7%0.5%1.1 $4.30 9/15/202451,500 shares $256,985.00 +112.8%0.7%1.4 $4.99 8/31/202424,200 shares $126,566.00 -9.7%0.3%0.6 $5.23 8/15/202426,800 shares $130,784.00 -71.3%0.4%0.5 $4.88 Get the Latest News and Ratings for HOOK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hookipa Pharma and its competitors with MarketBeat's FREE daily newsletter. 7/31/202493,400 shares $543,588.00 -2.0%1.2%1.6 $5.82 7/15/202495,300 shares $564,176.00 +47.1%1.2%1.1 $5.92 6/30/202464,800 shares $383,486.40 -85.7%0.8%0.7 $5.92 6/15/2024453,000 shares $336,805.50 -11.6%0.6%0.5 $0.74 5/31/2024512,400 shares $406,845.60 -38.0%0.7%0.6 $0.79 5/15/2024826,200 shares $709,705.80 +28.4%1.1%1 $0.86 4/30/2024643,700 shares $571,155.01 +103.3%0.9%0.8 $0.89 4/15/2024316,700 shares $240,692.00 +0.3%0.5%0.5 $0.76 3/31/2024315,900 shares $224,920.80 -5.3%0.5%0.6 $0.71 3/15/2024333,400 shares $239,714.60 +11.3%0.6%0.1 $0.72 2/29/2024299,500 shares $230,016.00 -10.0%0.5%0.1 $0.77 2/15/2024332,600 shares $219,516.00 -25.4%0.6%0.1 $0.66 1/31/2024446,100 shares $277,072.71 -28.1%0.8%0.2 $0.62 1/15/2024620,200 shares $474,390.98 -21.0%1.0%0.3 $0.76 12/31/2023785,400 shares $636,174.00 +142.9%1.3%0.3 $0.81 12/15/2023323,300 shares $211,114.90 -29.6%0.4%0.1 $0.65 11/30/2023459,000 shares $261,171.00 +99.5%0.6%1 $0.57 11/15/2023230,100 shares $109,297.50 -26.7%0.3%0.5 $0.48 10/31/2023313,900 shares $135,604.80 -10.5%0.4%0.9 $0.43 10/15/2023350,800 shares $191,536.80 -12.1%0.5%0.9 $0.55 9/30/2023399,000 shares $245,784.00 +68.9%0.5%1 $0.62 9/15/2023236,200 shares $165,340.00 +5.2%0.3%0.5 $0.70 8/31/2023224,600 shares $147,113.00 -20.5%0.3%0.3 $0.66 8/15/2023282,400 shares $206,152.00 -2.0%0.4%0.3 $0.73 7/31/2023288,200 shares $227,678.00 -64.2%0.4%0.2 $0.79 7/15/2023805,900 shares $710,964.98 -11.5%1.2%0.5 $0.88 6/30/2023910,600 shares $801,328.00 +26.3%1.4%0.6 $0.88 6/15/2023721,000 shares $771,470.00 +951.0%1.1%0.5 $1.07 5/31/202368,600 shares $89,866.00 -78.2%0.1%0.1 $1.31 5/15/2023314,900 shares $585,714.00 No Change0.7%0.4 $1.86 10/31/2022879,900 shares $1.14 million -4.3%N/A0.9 $1.29 10/15/2022919,600 shares $1.09 million -9.8%N/A1 $1.19 9/30/20221,020,000 shares $1.37 million +2.0%N/A4.9 $1.34 9/15/20221,000,000 shares $1.41 million -3.9%N/A3.7 $1.41Is AI Hype Hiding the Big Picture? (Ad)Jeff Bezos has loaded up on a tiny company being called "the Next Nvidia." If you've never heard of what I call "QaaS" technology, you need to see this now.Click here and get the details now. 8/31/20221,040,000 shares $1.55 million -17.5%N/A3.2 $1.49 8/15/20221,260,000 shares $2.17 million -46.2%N/A3.1 $1.73 7/31/20222,340,000 shares $3.21 million -2.5%N/A5.3 $1.37 7/15/20222,400,000 shares $3.96 million -29.6%N/A5.4 $1.65 6/30/20223,410,000 shares $5.56 million -14.1%N/A5.6 $1.63 6/15/20223,970,000 shares $6.67 million -3.6%N/A4.6 $1.68 5/31/20224,120,000 shares $7.09 million -0.7%N/A4.2 $1.72 5/15/20224,150,000 shares $5.69 million +2.7%N/A1.2 $1.37 4/30/20224,040,000 shares $6.06 million +5.2%N/A0.6 $1.50 4/15/20223,840,000 shares $6.87 million -2.5%N/A0.6 $1.79 3/31/20223,940,000 shares $8.98 million +1.8%N/A0.6 $2.28 3/15/20223,870,000 shares $5.84 million -16.8%N/A0.6 $1.51 2/28/20224,650,000 shares $11.16 million +63.7%27.7%0.8 $2.40 2/15/20222,840,000 shares $3.81 million +15.5%15.4%0.5 $1.34 1/31/20222,460,000 shares $3.69 million +9.3%14.3%7.9 $1.50 1/15/20222,250,000 shares $4.61 million +5.1%N/A0 $2.05 12/31/20212,140,000 shares $4.99 million +0.9%12.3%9.7 $2.33 12/15/20212,120,000 shares $5.81 million No Change12.2%10 $2.74 11/30/20212,120,000 shares $6.85 million +0.5%12.3%9.7 $3.23 11/15/20212,110,000 shares $8.31 million -5.0%12.2%9.7 $3.94 10/29/20212,220,000 shares $10.81 million +0.9%12.9%10.7 $4.87 10/15/20212,200,000 shares $11.79 million -0.5%12.7%9.5 $5.36 9/30/20212,210,000 shares $13.02 million -9.1%12.8%8.6 $5.89 9/15/20212,430,000 shares $15.26 million -8.3%14.1%8.2 $6.28 8/31/20212,650,000 shares $18.26 million -2.2%15.4%7.8 $6.89 8/13/20212,710,000 shares $18.70 million -0.4%15.7%6.3 $6.90 7/30/20212,720,000 shares $21.03 million +6.7%15.8%5.9 $7.73 7/15/20212,550,000 shares $20.71 million +1.2%14.8%5.8 $8.12 6/30/20212,520,000 shares $23.08 million +0.8%14.7%6 $9.16 6/15/20212,500,000 shares $24 million +9.7%14.5%6.5 $9.60 5/28/20212,280,000 shares $38.05 million +49.0%13.3%6.5 $16.69 5/14/20211,530,000 shares $25.77 million +10.9%8.9%6.6 $16.84 4/30/20211,380,000 shares $17.33 million +0.7%8.1%6.9 $12.56 4/15/20211,370,000 shares $17.30 million +0.7%N/A0 $12.63 3/31/20211,360,000 shares $18.14 million +5.4%8.2%7.4 $13.34 3/15/20211,290,000 shares $15.78 million No Change8.0%7.5 $12.23 2/26/20211,290,000 shares $15.03 million -0.8%8.0%8.5 $11.65 2/12/20211,300,000 shares $15.24 million +5.7%8.1%9 $11.72 1/29/20211,230,000 shares $13.09 million +3.4%7.6%10.2 $10.64 1/15/20211,190,000 shares $13.07 million +0.9%7.4%10.9 $10.98 12/31/20201,180,000 shares $13.45 million +0.9%8.2%12.3 $11.40 12/15/20201,170,000 shares $14.11 million +31.1%8.1%13.3 $12.06 11/30/2020892,600 shares $9.88 million +0.5%7.3%10.3 $11.07 11/15/2020887,900 shares $9.77 million +0.4%7.3%15.6 $11.00 10/30/2020884,000 shares $8.76 million +0.7%7.5%15.5 $9.91 10/15/2020877,900 shares $8.60 million +0.5%7.5%15.3 $9.80 9/30/2020874,000 shares $8.28 million +4.4%7.4%14.1 $9.47 9/15/2020837,400 shares $8.78 million +0.7%7.1%12.2 $10.49 8/31/2020831,700 shares $7.44 million -2.4%7.1%14.6 $8.94 8/14/2020851,800 shares $8.68 million -0.5%7.2%14.5 $10.19Is AI Hype Hiding the Big Picture? (Ad)Jeff Bezos has loaded up on a tiny company being called "the Next Nvidia." If you've never heard of what I call "QaaS" technology, you need to see this now.Click here and get the details now. 7/31/2020856,400 shares $8.27 million +4.4%7.4%11.6 $9.66 7/15/2020820,700 shares $8.07 million +0.2%7.1%10.4 $9.83 6/30/2020819,200 shares $9.63 million +8.8%7.1%10.5 $11.75 6/15/2020753,100 shares $8.64 million +4.1%6.5%10.3 $11.47 5/29/2020723,700 shares $7.84 million +300.5%6.2%9.2 $10.84 5/15/2020180,700 shares $1.71 million -10.5%1.6%2.3 $9.45 4/30/2020202,000 shares $1.79 million +17.4%1.7%3 $8.86 4/15/2020172,100 shares $1.38 million +3.7%1.5%2.4 $8.00 3/31/2020166,000 shares $1.35 million +38.6%1.4%2.2 $8.15 3/13/2020119,800 shares $956,004.00 -10.9%N/A2.1 $7.98 2/28/2020134,400 shares $1.01 million -3.6%N/A1.3 $7.51 2/14/2020139,400 shares $1.43 million -4.4%1.2%1.2 $10.24 1/31/2020145,800 shares $1.71 million -25.9%1.3%1.3 $11.73 1/15/2020196,700 shares $2.46 million -33.9%1.7%1.9 $12.49 12/31/2019297,700 shares $3.59 million +213.4%2.6%3.3 $12.06 HOOK Short Interest - Frequently Asked Questions What is Hookipa Pharma's current short interest? Short interest is the volume of Hookipa Pharma shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 36,200 shares of HOOK short. 0.47% of Hookipa Pharma's shares are currently sold short. Learn More on Hookipa Pharma's current short interest. What is a good short interest ratio for Hookipa Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HOOK shares currently have a short interest ratio of 1.0. Learn More on Hookipa Pharma's short interest ratio. What is a good short interest percentage for Hookipa Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.47% of Hookipa Pharma's floating shares are currently sold short. Is Hookipa Pharma's short interest increasing or decreasing? Hookipa Pharma saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 36,200 shares, an increase of 39.2% from the previous total of 26,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Hookipa Pharma's float size? Hookipa Pharma currently has issued a total of 12,060,000 shares. Some of Hookipa Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Hookipa Pharma currently has a public float of 7,760,000 shares. How does Hookipa Pharma's short interest compare to its competitors? 0.47% of Hookipa Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Hookipa Pharma: Organigram Holdings Inc. (3.02%), LifeVantage Co. (2.58%), Skye Bioscience, Inc. (8.88%), Puma Biotechnology, Inc. (9.07%), Checkpoint Therapeutics, Inc. (14.88%), Context Therapeutics Inc. (1.72%), Ventyx Biosciences, Inc. (14.88%), Repare Therapeutics Inc. (2.61%), PepGen Inc. (3.12%), Inventiva S.A. (0.82%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Hookipa Pharma stock? Short selling HOOK is an investing strategy that aims to generate trading profit from Hookipa Pharma as its price is falling. HOOK shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hookipa Pharma? A short squeeze for Hookipa Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HOOK, which in turn drives the price of the stock up even further. How often is Hookipa Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HOOK, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies OGI Short Interest LFVN Short Interest SKYE Short Interest PBYI Short Interest CKPT Short Interest CNTX Short Interest VTYX Short Interest RPTX Short Interest PEPG Short Interest IVA Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HOOK) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hookipa Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hookipa Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
